Usen Kesiena, Laboratory Technologist at Edwin Clark University, shared a post on LinkedIn:
“I am excited to share that I recently earned a Certificate of Attendance from Proteintech Group for successfully completing the webinar “Culturing Kidney Organoids: Best Practices for Differentiation and Long-Term Maintenance.”
My sincere thanks to Proteintech Group and Afrida Rahman-Enyart for organizing an educative and insightful event that greatly enhanced my understanding of organoid systems as transformative models for exploring human development, unraveling disease mechanisms, and advancing therapeutic testing. Organoids represent an exciting frontier because they allow us to reconstruct key features of human tissue architecture in the lab. This capacity to mimic cellular complexity and interactions makes them especially valuable for unraveling the biology of cancer, from how tumors evolve to how they resist treatment.
With my background in biochemistry, molecular biology, and immunohistochemistry, I have long been interested in how experimental systems can be used to better understand cancer initiation and progression. Immunohistochemistry has given me valuable insights into how protein expression and localization shape tumor behavior within complex tissue contexts. This is why I am especially intrigued by the potential of organoid platforms, they provide a more physiologically relevant way to study tumor dynamics, treatment responses, and cellular interactions that are often lost in traditional culture systems.
The recent Proteintech Group webinar helped simplify and expand my understanding of how organoids can be leveraged for such investigations. Their ability to capture patient-specific characteristics offers a powerful bridge between fundamental cancer research and personalized medicine, enabling discoveries that could directly inform therapeutic strategies.
This training also aligns with my broader research interest in how cells adapt to stressors such as radiation exposure and metabolic shifts. I am excited to integrate these skills into my research journey and to use them as a foundation for advancing translational applications in cancer biology and therapeutic innovation.”